Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jan 7:11:1540134.
doi: 10.3389/fsurg.2024.1540134. eCollection 2024.

Editorial: Tailoring treatment in invasive and non-invasive cervical pathology volume II

Violante Di Donato  1 , Tullio Golia D'Augè  1 , Alejandro Soderini  2 , Andrea Giannini  3 , Francesco Plotti  4
Affiliations
Editorial

Editorial: Tailoring treatment in invasive and non-invasive cervical pathology volume II

Violante Di Donato et al. Front Surg. .
No abstract available

Keywords: cervical cancer management; cost-effectiveness; diagnostic advancements; gynecological pathology; immunotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Tailoring treatment in invasive and non-invasive cervical pathology volume II

References

    1. World Health Organization. Cervical cancer. Available online at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer (cited November 13, 2024).
    1. Bogani G, Sopracordevole F, Ciavattini A, Vizza E, Vercellini P, Ghezzi F, et al. HPV Persistence after cervical surgical excision of high-grade cervical lesions. Cancer Cytopathol. (2024) 132(5):268–9. 10.1002/cncy.22760 - DOI - PubMed
    1. D’Oria O, Bogani G, Cuccu I, D’Auge TG, Di Donato V, Caserta D, et al. Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature. Expert Opin Pharmacother. (2024) 25(1):55–65. 10.1080/14656566.2023.2298329 - DOI - PubMed
    1. Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P, et al. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: a focus on the potential role of vaccination. Tumori. (2024) 110(2):139–45. 10.1177/03008916231208344 - DOI - PubMed
    1. Amantea C, Foschi N, Gavi F, Borrelli I, Rossi MF, Spuntarelli V, et al. HPV Vaccination adherence in working-age men: a systematic review and meta-analysis. Vaccines. (2023) 11(2):443. 10.3390/vaccines11020443 - DOI - PMC - PubMed

Publication types

LinkOut - more resources